Brought to you by 
For $450mm in cash, bioMerieux scoops up BioFire
25 Sep 2020
Executive Summary
Leading diagnostics firm bioMerieux SA (a division of Institut Merieux) has agreed to acquire private US molecular biology specialist BioFire Diagnostics Inc. for $450mm in cash, plus the assumption of debt.
Deal Industry
- In Vitro Diagnostics
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
For $450mm in cash, bioMerieux scoops up BioFire
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice